abstract |
The present invention relates to the use of non-ergot dopamine D2 / D3 receptor inhibitors, or pharmaceutically acceptable acid addition salts thereof, in the preparation of a medicament for the treatment of fibromyalgia. More particularly, the invention is a dopamine agonist, tetrahydrobenzothiazole or 3 (H) -indolone compounds, in particular 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole and 4- [2- (dipropylamino) ethyl] -1. 3-dihydro-2H-indol-2-one for the manufacture of a medicament for the treatment of fibromyalgia. SHE |